arnessing electricity for medicinal purposes predates Benjamin Franklin and his famous kite experiment. The ancient Greeks used the shock of a torpedo ray fish (also known as an electric eel), which can deliver up to 220 volts for pain relief during surgery and childbirth, as well as for the treatment of headaches. Scribonius Largus, the court physician to the Roman emperor Claudius, was the first to record such use of electricity to treat headaches and gout pain in 46 AD (Bullock, Hopkins, Popper, & Ray, 2005). Fast forward 2 millennia and practitioners are now using an elegant version of microcurrent to treat the body and mind. Cranial electro therapy stimulation (CES) is a Food and Drug Administration (FDA)approved modality for the treatment of anxiety, insomnia, and depression (Cranial electrotherapy stimulator, 21 Code of Federal Regulations [CFR], § 882.5800, 2013). CES research has made remarkable advances over the last 100 years, paralleling the direction of modern health care science, with the most recent studies being doubleblind, shamcontrolled randomized clinical trials (RCT), the gold standard in evidencebased medicine.As Henry Nasrallah pointed out in his description of the future of behav ioral health, neurostimulation for brain repair is one of the top six trends in clinical practice, along with pharmacogenomics, targeting neuroplasticity